An immunocompetent patient with a nonsense mutation in NHEJ1 gene

Hossein Esmaeilzadeh1,2, Mohammad Reza Bordbar3, Zahra Hojaji2

  • 1Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

BMC Medical Genetics
|March 23, 2019
PubMed
Abstract

Insights

A pathogenic mutation in the NHEJ1 gene, typically linked to immunodeficiency, did not cause clinical immune deficiency in one patient. This highlights the role of alternative DNA repair pathways in maintaining genetic stability.

Area of Science:

  • Genetics
  • Immunology
  • Molecular Biology

Background:

  • DNA double-strand breaks (DSBs) are critical DNA lesions repaired by homologous recombination or non-homologous end-joining (NHEJ).
  • NHEJ is crucial for V(D)J recombination and is the primary DSB repair pathway in higher eukaryotes.
  • Mutations in the NHEJ1 gene are often associated with severe combined immunodeficiency (SCID).

Observation:

  • A 3.5-year-old girl, homozygous for a nonsense mutation in NHEJ1, presented with failure to thrive, microcephaly, and autoimmune hemolytic anemia.
  • The patient's autoimmune hemolytic anemia responded to prednisolone treatment.
  • Despite the pathogenic NHEJ1 mutation, the patient remained clinically immunocompetent.

Findings:

  • This case report details a patient with a pathogenic NHEJ1 mutation who did not exhibit clinical immunodeficiency.
  • The findings suggest the involvement of alternative end-joining pathways in compensating for NHEJ1 defects.
  • Genetic stability was maintained despite the presence of a mutation in a key DNA repair gene.

Implications:

  • Pathogenic mutations in the NHEJ pathway are not always indicative of clinical immunodeficiency.
  • Alternative DNA repair mechanisms can compensate for defects in canonical NHEJ.
  • Clinicians should consider the possibility of immunocompetence in patients with NHEJ pathway mutations.

Related Concept Videos

Mutations01:39

Mutations

Overview
94.4K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.4K
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
63.8K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.8K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

3.4K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
862